OLYSIO® sales during the fourth quarter 2014 Stockholm,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
OLYSIO® sales during the fourth quarter 2014

Stockholm, Sweden — Medivir AB (OMX: MVIR) announces that the global fourth quarter net sales of OLYSIO® (simeprevir) amounted to 321 MUSD, of which 256 MUSD were sales in the USA. Medivir’s royalties based on sales for the fourth quarter are calculated from the highest royalty tier and currency conversion from USD to Euro is based on the YTD exchange rate. The royalty amounted to 220 MSEK (23.1 MEUR). OLYSIO® global net sales Sales in MUSD Market Q4 2014  Q3 2014   Q2 2014   Q1 2014 US 256 671 725 291 RoW 65 125 106 63 Total global net sales MUSD 321 796 831 354 Medivir will publish its Financial Statement on February 27, 2015 at 8.30 CET followed by a conference call for investors, analysts and the media at 14.00 CET. More information about the conference call/webcast will be posted at www.medivir.com. For more information please contact: Rein Piir, EVP Corporate Affairs & IR, mobile: +46 708 537 292 Medivir is required under the Securities Markets Act to make the information in this press release public. The information was submitted for publication at 13.55 CET on 20 January 2015. About Simeprevir (OLYSIO®) Simeprevir is an NS3/4A protease inhibitor jointly developed by Janssen Sciences Ireland UC and Medivir AB and has been approved for the treatment of chronic hepatitis C infection as a component of a combination antiviral treatment regimen in 36 countries worldwide. In November 2014 simeprevir was approved, in combination with sofosbuvir as an all-oral, interferon- and ribavirin-free treatment option for genotype 1 chronic hepatitis C (CHC) infection in adult patients as part of a combination antiviral treatment regimen. Simeprevir efficacy has been established in HCV genotype 1 and HCV genotype 4 infected patients with compensated liver disease, including cirrhosis. Janssen is responsible for the global clinical development of simeprevir and has exclusive, worldwide marketing rights, except in the Nordic countries. Medivir AB retains marketing rights for simeprevir in these countries under the marketing authorization held by Janssen-Cilag International NV. Simeprevir is marketed under the trade name OLYSIO® in the U.S., European Union, Mexico, Australia and Saudi Arabia, Sovriad® in Japan and Russia and Galexos™ in Canada. About Medivir Medivir is an emerging and profitable research‐based pharmaceutical company with an established marketing and sales organisation in the Nordic region with a broad portfolio of prescription pharmaceuticals. Medivir receives royalties from Johnson & Johnson on the global sales of the hepatitis C pharmaceutical, OLYSIO®. In addition, revenues for sales of OLYSIO in the Nordic region are generated through the company’s own sales and marketing organisation. Medivir’s research and development portfolio of pharmaceuticals is based on the company’s expertise within protease inhibitor design and nucleoside/nucleotide science. The company’s research and development focus is within infectious diseases and oncology and the on-going clinical projects in osteoarthritis and neuropathic pain. Medivir is listed on the Nasdaq Stockholm Mid Cap List.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

American Lung Association Tackles Indoor Pollution

Updated Category News Views 6

The Unseen Threat Lurking Indoors When you think about air pollution, your mind probably jumps to smog-choked city streets. But, surprise! The air inside your cozy living room could actually be pulling a fast one on you, being two to five times filthier than what’s outside. Now, that’s a hair-raising thought. A Closer Look at Indoor Air Hazards Folks don’t usually...

Continue Reading
Amanda Ortiz's Debut Album Inspires With Unique Voice

Updated Category News Views 34

A Debut Album Rich with Heart and Soul Straight outta Brooklyn, Amanda Ortiz, a songwriter born with Down syndrome, is making a splash with her debut album, Dear Amanda. This ain't just any release—it's one packed with raw emotion that'll grab your attention and keep it. The music world gets shaken up every once in a while, and this is one of those times. Embracing...

Continue Reading
EverSmith Rolls Out Training Hub to Propel Franchise Growth

Updated Category News Views 4

Big Ambitions Nestled in Milford, Ohio Beneath the glow of fluorescent lights in a fresh-to-the-world 12,000-square-foot box of opportunity, EverSmith Brands is betting on big returns. EverHUB has opened its doors, aiming to be the cradle that hatches their aggressive franchise dreams into reality. It's not just brick and mortar—it’s the manifestation of their grand...

Continue Reading
Husqvarna Faces EU's Anti-Dumping Probe on Mowers

Updated Category News Views 5

Investigating Robotic Mower Imports Some news for Husqvarna Group today, where the European Commission dropped a disclosure that’s sure to keep the execs on their toes. Yeah, we’re talking about that anti-dumping investigation, where the EU’s been eyeing imports of robotic mowers from China. Now, this isn’t the final bell—just another step in an ongoing...

Continue Reading
TeamLogic IT Celebrates Franchise Triumphs at Summit

Updated Category News Views 4

A Vibrant Gathering of IT Luminaries In a bustling corner of Mission Viejo, California, TeamLogic IT brought together its hive of tech-savvy franchisees and industry bigwigs for the annual Owners Summit. For the tech crowd, this wasn't just another rundown hotel conference — it was a vibrant celebration and brainstorming bonanza, all wrapped into one energizing week....

Continue Reading
One Times Square Candy Experience Offers Unique Halloween

Updated Category News Views 8

Halloween Takes Over Times Square A cold October breeze and you find One Times Square turning a new page. Forget the usual New Year's Ball hype. This time, they're throwing a Halloween bash that you haven't seen before. Kicking off October 24, the One Times Square Candy Experience is transforming itself into a sugary wonderland right in Manhattan's bustling heart. For a...

Continue Reading
Globus Medical Under Fire: Shareholders Investigate

Updated Category News Views 2

Ruffled Feathers at Globus Medical Inc. You ever get that feeling when a company's top brass might be playing tricks behind the boardroom doors? That's what's echoing through the finance corridors as Kuehn Law, PLLC collars some pretty heavy accusations against Globus Medical, Inc. (NYSE: GMED). Supposedly, some of those at the helm might've been caught with their hands...

Continue Reading
Duolingo Faces Class Action: Investors Brace for Impact

Updated Category News Views 2

Going Beyond Language Learning Hype Listen, it's not every day you wake up to a lawsuit calling out one of those seemingly indestructible tech darlings. Well, Duolingo (NASDAQ: DUOL) is caught in the crosshairs now. They face allegations of pulling the wool over investors' eyes about their monetization and growth tactics. If you snapped up some stock between May 2, 2025,...

Continue Reading
Teleste Unveils AI-Enhanced Rail Info Platform Innovation

Updated Category News Views 8

A Shake-Up in Rail Passenger Information Now, here's something from left field that might just have people paying attention while on the go. Teleste, a Finnish company, just put out a gem in rail passenger information systems with the introduction of Acapela's AI-based voice tech into their S-ARRIVE platform. Picture clearer, more natural announcements for every stop,...

Continue Reading
Compass Hit by Securities Fraud Suit; Investor Action Urged

Updated Category News Views 3

Trouble Brewing for Compass Investors Amidst Legal Storm In the tangled web of mergers and acquisitions, Compass, Inc. (NYSE: COMP) finds itself in a legal quagmire that has investors on edge. The stark reality of a securities fraud class action lawsuit has emerged, centered around Compass’s January 2026 merger with Anywhere Real Estate Inc. The Heart of the Allegations...

Continue Reading

Top 5 Most Recently Viewed Articles

Discover the Sleek and Stylish 2025 Toyota Corolla Today

Updated Category News Views 259

Explore the New 2025 Toyota Corolla For those in search of a stylish, fuel-efficient, and tech-savvy sedan, the 2025 Toyota Corolla has arrived and is ready to impress. This compact car is now available for drivers who desire a perfect blend of sophistication and practicality. Unveiling the Corolla's Features The 2025 Toyota Corolla combines sleek design with innovative...

Continue Reading
Royal Unibrew Reports on 2024 Performance and Future Plans

Updated Category News Views 235

Royal Unibrew's Annual Report Review for 2024 In a detailed announcement regarding Royal Unibrew's Annual Report for the year 2024, the company has presented a comprehensive view of its operations, performance metrics, and strategic direction. The report is not just a formality; it provides stakeholders significant insights into how the company navigated the challenges of...

Continue Reading
Mullen Group Ltd. Declares Exciting Monthly Dividend Growth

Updated Category News Views 88

Mullen Group Ltd. Declares Exciting Monthly Dividend Growth The Board of Directors at Mullen Group Ltd. recently made a notable announcement regarding their commitment to returning value to shareholders. This Canadian transport and logistics leader has declared a monthly dividend of $0.07 per Common Share. This decision showcases the corporation's robust financial...

Continue Reading
Avacta's AVA6000 Trials Show Exciting Results and Potential

Updated Category News Views 223

Avacta Unveils Encouraging Data for AVA6000 Trials Avacta Therapeutics is making strides in the field of oncology with its innovative approach to cancer treatment through peptide drug conjugates (PDC). The company has reported promising early efficacy and safety data from its lead program, AVA6000, which employs the cutting-edge pre|CISION® technology. AVA6000, a...

Continue Reading
SOS Inventory Updates Its Brand and Launches New Website

Updated Category News Views 365

SOS Inventory Unveils Comprehensive Rebrand SOS Inventory, recognized as a leading companion for QuickBooks in inventory management, has recently undergone a dynamic rebranding that reflects its ongoing commitment to providing exceptional inventory solutions to businesses everywhere. The transformation includes a newly designed website that enhances user experience and...

Continue Reading